New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
09:59 EDTMDCO, NGLS, STKL, SO, SDRL, R, IMO, MDP, HBAN, EPDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Enterprise Products (EPD) downgraded to Hold from Buy at Jefferies... Huntington Bancshares (HBAN) downgraded to Outperform from Strong Buy at Raymond James... Imperial Oil (IMO) downgraded to Sell from Hold at Desjardins... Meredith (MDP) downgraded to Neutral from Buy at Citigroup... Ryder (R) downgraded to Hold from Buy at Stifel... Seadrill (SDRL) downgraded to Neutral from Buy at BofA/Merrill... Southern Company (SO) downgraded to Sector Perform from Outperform at RBC Capital... SunOpta (STKL) downgraded to Sell from Hold at Desjardins... Targa Resources Partners (NGLS) downgraded to Hold from Buy at Jefferies... The Medicines Co. (MDCO) downgraded to Market Perform from Outperform at Leerink.
News For EPD;HBAN;MDP;IMO;R;SDRL;SO;STKL;NGLS;MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 15, 2014
16:07 EDTMDPMeredith secures rights to license Martha Stewart Living Magazine, website
Meredith Corporation (MDP) announced that it has entered into an agreement with Martha Stewart Living Omnimedia (MSO) to acquire the rights to Martha Stewart Living and www.marthastewart.com pursuant to a 10-year licensing agreement. Under the terms of the agreement, Meredith will lead sales and marketing, circulation, production, and other non-editorial functions of Martha Stewart Living and Martha Stewart Weddings magazines. Martha Stewart Living Omnimedia's editorial team will continue to create its highly regarded content. Additionally, Meredith will assume responsibility for the sales and marketing of www.marthastewart.com and www.marthastewartweddings.com and its related assets, including its vast video library. The agreement, which applies to the United States and Canada, is effective November 1. The agreement will not have a material effect on Meredith's FY15 Q2 financial performance, but will be accretive to Meredith's earnings for the second half of fiscal 2015 and in FY16.
10:13 EDTSOSouthern Company announces Plant Vogtle Unit 2 has resumed generation
Subscribe for More Information
07:09 EDTSDRLSeadrill initiated with a Buy at ISI Group
Subscribe for More Information
October 13, 2014
12:16 EDTNGLSOn The Fly: Midday Wrap
Stocks on Wall Street were slightly lower at midday amid light trading volume. Banks and bond markets are closed in observance of the Columbus Day holiday, though equity markets remain open. ECONOMIC EVENTS: In the U.S., no major economic data was reported. COMPANY NEWS: Shares of a number of freight train operators rose after The Wall Street Journal reported that one of the companies in the sector, CSX (CSX), was approached by a larger rival, Canadian Pacific (CP), about a possible merger. Following the Journal's report, CSX rose 10% and Canadian Pacific advanced 1%, while Norfolk Southern (NSC) and Kansas City Southern (KSU) both climbed about 3%... Chrysler returned to the U.S. stock market, as shares of Fiat Chrysler began trading on the New York Stock Exchange under the symbol "FCAU." MAJOR MOVERS: Among the notable gainers was J.C. Penney (JCP), which rose 3% after the company selected Marvin Ellison, who is currently executive vice president of stores at Home Depot (HD), to become its next CEO. Also higher were Atlas Energy (ATLS), which rose 20%, and Atlas Pipeline Partners (APL), which advanced 6%, after Targa Resources Partners (NGLS) and Targa Resources (TRGP) agreed to acquire Atlas Pipeline Partners for cash and stock valued at $38.66 per APL common unit and agreed to buy Atlas Energy following the company's spin-off of its non-midstream assets. Among the noteworthy losers was Aerohive Networks (HIVE), which plunged 30% after the company lowered its guidance for the third quarter, citing weaker-than-expected order volume near the quarter's end. Also lower were shares of GoPro (GPRO), which fell over 8% after a French journalist reported that the son of racing legend Michael Schumacher attributed the severity of his father's brain injury following a skiing accident on the GoPro camera mounted to his helmet. INDEXES: Near midday, the Dow was down 32.14, or 0.19%, to 16,511.96, the Nasdaq was down 7.97, or 0.19%, to 4,268.27, and the S&P 500 was down 6.85, or 0.36%, to 1,899.28.
10:29 EDTNGLSTarga says has no expecation of reducing headcount to create value
Subscribe for More Information
09:21 EDTNGLSOn The Fly: Pre-market Movers
Subscribe for More Information
08:38 EDTNGLSTarga Resources Partners to increase dividend by 4c post-closing
Subscribe for More Information
08:32 EDTNGLSAtlas Energy to host conference call
Subscribe for More Information
08:17 EDTNGLSTarga Resources Partners and Targa Resources to host conference call
Subscribe for More Information
07:57 EDTNGLSTarga Resources CEO says acquisition is 'compelling strategic opportunity'
Joe Bob Perkins, CEO of the Targa Resources and of the general partner of the Partnership, stated, "Both the Targa and Atlas management teams and our boards view this integrated transaction as a highly compelling strategic opportunity to combine two outstanding midstream businesses and create value for all shareholders and unitholders. We believe the combination provides our customers an enhanced midstream service offering, and presents our investors with an enterprise that has increased scale, diversity and growth. The acquisitions will significantly and immediately increase our scale and geographic diversity, accelerating the growth of our premier North American midstream platform. APL's footprint solidifies the Partnership's position as a leader in the Permian Basin, while adding top-tier assets in the Midcontinent and South Texas regions. Importantly, the combination of APL's NGL production with Targa Resources Partners' leading NGL downstream assets will allow the pro forma partnership to generate additional revenue along the NGL value chain, create additional attractive growth capital expenditure projects and accelerate current growth capital expenditure projects." The boards of the partnership (NGLS), the company (TGRP), ATLS (ATLS) and APL (APL) have each approved the respective merger agreements. Subject to the completion of the spin-off and customary approvals and conditions, including the expiration or termination of all waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act, the acquisitions are expected to close in 1Q15. The respective boards of APL, ATLS and the Company have voted to recommend the transaction to their unitholders and shareholders.
07:50 EDTNGLSAtlas Energy to spin-off non-midstream assets prior to acquisition by Targa
Prior to Targa Resources' (TRGP) acquisition of Atlas Energy (ATLS), ATLS will spin-off its non-midstream assets. After giving effect to the spin-off, ATLS's assets will solely comprise its general partner and incentive distribution rights interests in APL and 5.8M APL common units. Immediately following the spin-off and subject to the concurrent closing of the Partnership's acquisition of APL, Targa Resources will acquire Atlas Energy for total consideration of $1.87B, including 10.35M TRC shares valued at $1.26B based on the closing price of TRC's common stock on October 10 and $610M in cash. Targa Resources has arranged committed financing of $1.1B to replace its existing revolving credit facility and to fund the cash components of the transaction, including cash merger consideration and $149M related to change of control payments. Based on shares of TRC and units of ATLS outstanding as of September 30, current Targa Resources shareholders will own approximately 80% of the pro forma shares outstanding and current ATLS unitholders will own approximately 20%.
07:48 EDTNGLSTarga Resources sees 11%-13% distribution growth in 2015 following acquisition
For the Partnership, management expects to recommend a distribution increase 4c per limited partner unit at the first Bboard distribution declaration meeting after the transaction closes; which is expected to be in the first quarter of 2015. Assuming a first quarter close, the Partnership estimates full year 2015 pro forma distribution growth over full year 2014 of 11% 13%, and expects distribution coverage to be at or above the Partnership's stated target range of 1.1x 1.2x. In conjunction with the Partnership recommendation, management expects to recommend a dividend increase of 10c per share for Targa Resources following the closings of the transactions. Assuming a first quarter close and 11%-13% distribution growth at the Partnership, the company estimates full year 2015 pro forma dividend growth over full year 2014 of approximately 35%. The Company's estimated 2015 effective cash tax rate pro forma for the transaction is expected to be 10%-15% compared to 33% on a standalone basis. Targa Resources Corp. expects $1.00 - $2.00 per share dividend accretion over the long term
07:46 EDTNGLSTarga Resources to acquire Atlas Pipeline Partners, Atlas Energy
Subscribe for More Information
07:44 EDTNGLSTarga Resources to acquire Atlas Pipeline Partners, Atlas Energy
07:25 EDTMDCOEuropean Association of Cardiothoracic Surgery to hold annual meeting
28th EACTS Annual Meeting is being held in Milan, Italy on October 11-15.
October 10, 2014
13:06 EDTEPDEnterprise Products ups quarterly dividend by 5.8% to 36.5c
Subscribe for More Information
07:14 EDTMDCOThe Medicines Co's Q3 Angiomax estimate lowered at Credit Suisse
Subscribe for More Information
October 9, 2014
16:57 EDTMDCOThe Medicines Co. announces journal publication of SOLO II phase 3 trial
The Medicines Company announced the publication of the results from the SOLO II phase 3 clinical trial of ORBACTIV, or oritavancin, for injection in the journal Clinical Infectious Diseases. ORBACTIV, is the first and only single dose intravenous antibiotic approved by FDA for the treatment of adults with Acute Bacterial Skin and Skin Structure Infections, or ABSSSI, caused or suspected to be caused by susceptible isolates of designated Gram-positive pathogens. The publication reported that a single, once only, 1200 mg intravenous dose of ORBACTIVTM was non-inferior to twice-daily intravenous dosing of vancomycin given for 7 to 10 days in patients with ABSSSI caused or suspected to be caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. A single 1200 mg IV dose of ORBACTIV results in efficacy in ABSSSIs that is comparable and statistically non-inferior to vancomycin administered intravenously for 7-10 days. ORBACTIV had a safety profile comparable to vancomycin when monitored for up to 60 days following a single dose, with similar intensity, onset and duration of AEs.
October 8, 2014
10:06 EDTRStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
October 6, 2014
14:16 EDTEPDOiltanking Partners downgraded to Neutral from Buy at Ladenburg
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use